U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 56

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr16:28943345
GRCh38:
Chr16:28932024
CD19F8LImmunodeficiency, common variable, 3Uncertain significance
(Jun 28, 2021)
criteria provided, single submitter
2.
GRCh37:
Chr16:28949986
GRCh38:
Chr16:28938665
CD19not provided, Immunodeficiency, common variable, 3Conflicting interpretations of pathogenicity
(May 12, 2022)
criteria provided, conflicting interpretations
3.
GRCh37:
Chr16:28947872
GRCh38:
Chr16:28936551
CD19Q256H, Q345HImmunodeficiency, common variable, 3, Immunodeficiency, common variable, 2, not provided
Uncertain significance
(Aug 7, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr16:28943806
GRCh38:
Chr16:28932485
CD19R76Snot provided, Immunodeficiency, common variable, 3Uncertain significance
(Aug 15, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr16:28949164
GRCh38:
Chr16:28937843
CD19not provided, Immunodeficiency, common variable, 3Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr16:28943368
GRCh38:
Chr16:28932047
CD19M16TImmunodeficiency, common variable, 3Likely benign
(May 21, 2020)
no assertion criteria provided
7.
GRCh37:
Chr16:28946783
GRCh38:
Chr16:28935462
CD19L285Pnot providedUncertain significance
(Jan 3, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr16:28947515
GRCh38:
Chr16:28936194
CD19T330Anot provided, Immunodeficiency, common variable, 3Uncertain significance
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr16:28946775
GRCh38:
Chr16:28935454
CD19H282Qnot provided, Immunodeficiency, common variable, 3Uncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr16:28944783
GRCh38:
Chr16:28933462
CD19R263Hnot provided, Immunodeficiency, common variable, 3Uncertain significance
(May 30, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr16:28944682
GRCh38:
Chr16:28933361
CD19E229DImmunodeficiency, common variable, 3Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
12.
GRCh37:
Chr16:28944406
GRCh38:
Chr16:28933085
CD19R177TImmunodeficiency, common variable, 3Uncertain significance
(Jan 15, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr16:28944364
GRCh38:
Chr16:28933043
CD19R163HImmunodeficiency, common variable, 3, not providedUncertain significance
(Aug 20, 2021)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr16:28950650
GRCh38:
Chr16:28939329
CD19Immunodeficiency, common variable, 3Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr16:28943901
GRCh38:
Chr16:28932580
CD19Q108PImmunodeficiency, common variable, 3, not providedConflicting interpretations of pathogenicity
(Jul 7, 2022)
criteria provided, conflicting interpretations
16.
GRCh37:
Chr16:28943824
GRCh38:
Chr16:28932503
CD19Immunodeficiency, common variable, 3Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
17.
GRCh37:
Chr16:28950511
GRCh38:
Chr16:28939190
CD19Immunodeficiency, common variable, 3Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr16:28949129
GRCh38:
Chr16:28937808
CD19R490QImmunodeficiency, common variable, 3, not providedUncertain significance
(Aug 13, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr16:28943382
GRCh38:
Chr16:28932061
CD19E21QImmunodeficiency, common variable, 3, not providedUncertain significance
(Feb 8, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr16:28943756
GRCh38:
Chr16:28932435
CD19P60Snot provided, Immunodeficiency, common variable, 3Uncertain significance
(Jan 14, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr16:28948459
GRCh38:
Chr16:28937138
CD19Immunodeficiency, common variable, 3Likely pathogenic
(Jul 5, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr16:28943725
GRCh38:
Chr16:28932404
CD19not provided, Immunodeficiency, common variable, 3Conflicting interpretations of pathogenicity
(Oct 16, 2022)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr16:28947879
GRCh38:
Chr16:28936558
CD19Y348H, Y259HImmunodeficiency, common variable, 3Uncertain significance
(Apr 27, 2019)
criteria provided, single submitter
24.
GRCh37:
Chr16:28950248
GRCh38:
Chr16:28938927
CD19G547fs, G457fsnot provided, Immunodeficiency, common variable, 3Conflicting interpretations of pathogenicity
(Jul 30, 2021)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr16:28950626
GRCh38:
Chr16:28939305
CD19Immunodeficiency, common variable, 3Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr16:28950597
GRCh38:
Chr16:28939276
CD19Immunodeficiency, common variable, 3Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr16:28950546
GRCh38:
Chr16:28939225
CD19Immunodeficiency, common variable, 3Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
28.
GRCh37:
Chr16:28950517
GRCh38:
Chr16:28939196
CD19Immunodeficiency, common variable, 3Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr16:28950483
GRCh38:
Chr16:28939162
CD19Immunodeficiency, common variable, 3Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr16:28950295
GRCh38:
Chr16:28938974
CD19Immunodeficiency, common variable, 3Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr16:28950189
GRCh38:
Chr16:28938868
CD19not provided, Immunodeficiency, common variable, 3Conflicting interpretations of pathogenicity
(Oct 20, 2022)
criteria provided, conflicting interpretations
32.
GRCh37:
Chr16:28950179
GRCh38:
Chr16:28938858
CD19not provided, Immunodeficiency, common variable, 3Conflicting interpretations of pathogenicity
(Apr 15, 2022)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr16:28950051
GRCh38:
Chr16:28938730
CD19R514H, R515Hnot provided, not specified, Immunodeficiency, common variable, 3
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr16:28948843
GRCh38:
Chr16:28937522
CD19not provided, Immunodeficiency, common variable, 3Uncertain significance
(Jan 14, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr16:28948783
GRCh38:
Chr16:28937462
CD19not provided, Immunodeficiency, common variable, 3Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr16:28948667
GRCh38:
Chr16:28937346
CD19S425F, S336FImmunodeficiency, common variable, 3, not providedConflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr16:28948597
GRCh38:
Chr16:28937276
CD19E402K, E313Knot provided, Immunodeficiency, common variable, 3Uncertain significance
(Jun 29, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr16:28946752
GRCh38:
Chr16:28935431
CD19not provided, Immunodeficiency, common variable, 3Conflicting interpretations of pathogenicity
(Oct 31, 2022)
criteria provided, conflicting interpretations
39.
GRCh37:
Chr16:28944700
GRCh38:
Chr16:28933379
CD19not provided, Immunodeficiency, common variable, 3Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr16:28944403
GRCh38:
Chr16:28933082
CD19P176L, P87Lnot provided, Immunodeficiency, common variable, 3Uncertain significance
(Aug 1, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr16:28944396
GRCh38:
Chr16:28933075
CD19L174Vnot provided, not specified, Immunodeficiency, common variable, 3
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr16:28944282
GRCh38:
Chr16:28932961
CD19not provided, Immunodeficiency, common variable, 3Benign/Likely benign
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr16:28944271
GRCh38:
Chr16:28932950
CD19L132R, L43Rnot provided, Immunodeficiency, common variable, 3Conflicting interpretations of pathogenicity
(Oct 25, 2022)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr16:28944266
GRCh38:
Chr16:28932945
CD19not provided, Immunodeficiency, common variable, 3Conflicting interpretations of pathogenicity
(Oct 21, 2022)
criteria provided, conflicting interpretations
45.
GRCh37:
Chr16:28944260
GRCh38:
Chr16:28932939
CD19not provided, Immunodeficiency, common variable, 3Conflicting interpretations of pathogenicity
(Aug 23, 2022)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr16:28944257
GRCh38:
Chr16:28932936
CD19Immunodeficiency, common variable, 3, not providedBenign/Likely benign
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr16:28943749
GRCh38:
Chr16:28932428
CD19not provided, Immunodeficiency, common variable, 3Conflicting interpretations of pathogenicity
(Sep 14, 2022)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr16:28943338
GRCh38:
Chr16:28932017
CD19L6RImmunodeficiency, common variable, 3Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr16:28943306
GRCh38:
Chr16:28931985
CD19Immunodeficiency, common variable, 3Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr16:28950266-28950293
GRCh38:
Chr16:28938945-28938972
CD19Immunodeficiency, common variable, 3Pathogenic
(Sep 13, 2016)
no assertion criteria provided
51.
GRCh37:
Chr16:28949121
GRCh38:
Chr16:28937800
CD19S489fs, S400fsImmunodeficiency, common variable, 3Pathogenic
(Sep 13, 2016)
no assertion criteria provided
52.
GRCh37:
Chr16:28943734
GRCh38:
Chr16:28932413
CD19W52CImmunodeficiency, common variable, 3Pathogenic
(Sep 13, 2016)
no assertion criteria provided
53.
GRCh37:
Chr16:28947473
GRCh38:
Chr16:28936152
CD19Immunodeficiency, common variable, 3Pathogenic
(Sep 13, 2016)
no assertion criteria provided
54.
GRCh37:
Chr16:28944833
GRCh38:
Chr16:28933512
CD19not provided, Immunodeficiency, common variable, 3Uncertain significance
(Jan 13, 2018)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr16:28948956-28948957
GRCh38:
Chr16:28937635-28937636
CD19N374fs, N463fsImmunodeficiency, common variable, 3Pathogenic
(May 4, 2006)
no assertion criteria provided
56.
GRCh37:
Chr16:28947495-28947496
GRCh38:
Chr16:28936174-28936175
CD19R236fs, R325fsImmunodeficiency, common variable, 3Pathogenic
(May 4, 2006)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination